Logo image of NBR

NABORS INDUSTRIES LTD (NBR) Stock Fundamental Analysis

NYSE:NBR - New York Stock Exchange, Inc. - BMG6359F1370 - Common Stock - Currency: USD

28.91  -0.65 (-2.2%)

Fundamental Rating

2

Overall NBR gets a fundamental rating of 2 out of 10. We evaluated NBR against 62 industry peers in the Energy Equipment & Services industry. NBR may be in some trouble as it scores bad on both profitability and health. NBR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

NBR had negative earnings in the past year.
In the past year NBR had a positive cash flow from operations.
In the past 5 years NBR always reported negative net income.
Each year in the past 5 years NBR had a positive operating cash flow.
NBR Yearly Net Income VS EBIT VS OCF VS FCFNBR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

NBR's Return On Assets of -4.57% is on the low side compared to the rest of the industry. NBR is outperformed by 77.42% of its industry peers.
NBR's Return On Equity of -152.45% is on the low side compared to the rest of the industry. NBR is outperformed by 95.16% of its industry peers.
NBR's Return On Invested Capital of 4.68% is on the low side compared to the rest of the industry. NBR is outperformed by 62.90% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for NBR is below the industry average of 8.11%.
The last Return On Invested Capital (4.68%) for NBR is above the 3 year average (3.54%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -4.57%
ROE -152.45%
ROIC 4.68%
ROA(3y)-4.38%
ROA(5y)-7.78%
ROE(3y)-88.52%
ROE(5y)-87.38%
ROIC(3y)3.54%
ROIC(5y)N/A
NBR Yearly ROA, ROE, ROICNBR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

The Operating Margin of NBR (7.94%) is worse than 62.90% of its industry peers.
NBR has a Gross Margin of 40.53%. This is in the better half of the industry: NBR outperforms 77.42% of its industry peers.
NBR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.94%
PM (TTM) N/A
GM 40.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.82%
GM growth 5Y2.06%
NBR Yearly Profit, Operating, Gross MarginsNBR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NBR is destroying value.
Compared to 1 year ago, NBR has more shares outstanding
Compared to 5 years ago, NBR has more shares outstanding
Compared to 1 year ago, NBR has an improved debt to assets ratio.
NBR Yearly Shares OutstandingNBR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
NBR Yearly Total Debt VS Total AssetsNBR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

Based on the Altman-Z score of 0.34, we must say that NBR is in the distress zone and has some risk of bankruptcy.
NBR has a Altman-Z score of 0.34. This is in the lower half of the industry: NBR underperforms 79.03% of its industry peers.
The Debt to FCF ratio of NBR is 185.39, which is on the high side as it means it would take NBR, 185.39 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of NBR (185.39) is worse than 64.52% of its industry peers.
NBR has a Debt/Equity ratio of 18.56. This is a high value indicating a heavy dependency on external financing.
NBR has a worse Debt to Equity ratio (18.56) than 93.55% of its industry peers.
Industry RankSector Rank
Debt/Equity 18.56
Debt/FCF 185.39
Altman-Z 0.34
ROIC/WACC0.68
WACC6.92%
NBR Yearly LT Debt VS Equity VS FCFNBR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

NBR has a Current Ratio of 1.75. This is a normal value and indicates that NBR is financially healthy and should not expect problems in meeting its short term obligations.
NBR has a Current ratio (1.75) which is comparable to the rest of the industry.
A Quick Ratio of 1.52 indicates that NBR should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.52, NBR is in line with its industry, outperforming 54.84% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.75
Quick Ratio 1.52
NBR Yearly Current Assets VS Current LiabilitesNBR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

3

3. Growth

3.1 Past

The earnings per share for NBR have decreased strongly by -280.81% in the last year.
The Revenue has decreased by -2.52% in the past year.
Measured over the past years, NBR shows a decrease in Revenue. The Revenue has been decreasing by -0.76% on average per year.
EPS 1Y (TTM)-280.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-147.04%
Revenue 1Y (TTM)-2.52%
Revenue growth 3Y13.25%
Revenue growth 5Y-0.76%
Sales Q2Q%0.11%

3.2 Future

NBR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.30% yearly.
Based on estimates for the next years, NBR will show a small growth in Revenue. The Revenue will grow by 7.81% on average per year.
EPS Next Y78.13%
EPS Next 2Y49.43%
EPS Next 3Y35.3%
EPS Next 5YN/A
Revenue Next Year11.97%
Revenue Next 2Y10.11%
Revenue Next 3Y7.81%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NBR Yearly Revenue VS EstimatesNBR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
NBR Yearly EPS VS EstimatesNBR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 50 -50 -100

2

4. Valuation

4.1 Price/Earnings Ratio

NBR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NBR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NBR Price Earnings VS Forward Price EarningsNBR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

91.94% of the companies in the same industry are more expensive than NBR, based on the Enterprise Value to EBITDA ratio.
NBR's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 30.81
EV/EBITDA 2.92
NBR Per share dataNBR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200

4.3 Compensation for Growth

NBR's earnings are expected to grow with 35.30% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y49.43%
EPS Next 3Y35.3%

0

5. Dividend

5.1 Amount

NBR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NABORS INDUSTRIES LTD

NYSE:NBR (4/25/2025, 10:31:23 AM)

28.91

-0.65 (-2.2%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)02-12 2025-02-12/amc
Earnings (Next)04-29 2025-04-29/amc
Inst Owners88.94%
Inst Owner Change0.54%
Ins Owners6.13%
Ins Owner Change7.14%
Market Cap416.30M
Analysts52
Price Target60.33 (108.68%)
Short Float %10.15%
Short Ratio2.8
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.01
Dividend Growth(5Y)-73.53%
DP-0.04%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-187.13%
Min EPS beat(2)-287.9%
Max EPS beat(2)-86.37%
EPS beat(4)0
Avg EPS beat(4)-168.42%
Min EPS beat(4)-287.9%
Max EPS beat(4)-86.37%
EPS beat(8)1
Avg EPS beat(8)-862.61%
EPS beat(12)2
Avg EPS beat(12)-690.71%
EPS beat(16)3
Avg EPS beat(16)-519.56%
Revenue beat(2)0
Avg Revenue beat(2)-1.39%
Min Revenue beat(2)-1.71%
Max Revenue beat(2)-1.08%
Revenue beat(4)1
Avg Revenue beat(4)-0.83%
Min Revenue beat(4)-1.71%
Max Revenue beat(4)1.05%
Revenue beat(8)1
Avg Revenue beat(8)-1.41%
Revenue beat(12)5
Avg Revenue beat(12)-0.51%
Revenue beat(16)8
Avg Revenue beat(16)-0.07%
PT rev (1m)-13.45%
PT rev (3m)-34.89%
EPS NQ rev (1m)-9.69%
EPS NQ rev (3m)-83.18%
EPS NY rev (1m)-9.32%
EPS NY rev (3m)-139.58%
Revenue NQ rev (1m)2.64%
Revenue NQ rev (3m)-7.27%
Revenue NY rev (1m)6.53%
Revenue NY rev (3m)-1.71%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.14
P/FCF 30.81
P/OCF 0.72
P/B 3.08
P/tB 3.08
EV/EBITDA 2.92
EPS(TTM)-19.65
EYN/A
EPS(NY)-4.3
Fwd EYN/A
FCF(TTM)0.94
FCFY3.25%
OCF(TTM)40.38
OCFY139.67%
SpS203.48
BVpS9.37
TBVpS9.37
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.57%
ROE -152.45%
ROCE 5.92%
ROIC 4.68%
ROICexc 5.2%
ROICexgc 5.2%
OM 7.94%
PM (TTM) N/A
GM 40.53%
FCFM 0.46%
ROA(3y)-4.38%
ROA(5y)-7.78%
ROE(3y)-88.52%
ROE(5y)-87.38%
ROIC(3y)3.54%
ROIC(5y)N/A
ROICexc(3y)4.37%
ROICexc(5y)N/A
ROICexgc(3y)4.37%
ROICexgc(5y)N/A
ROCE(3y)4.47%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.82%
GM growth 5Y2.06%
F-Score5
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 18.56
Debt/FCF 185.39
Debt/EBITDA 2.89
Cap/Depr 89.66%
Cap/Sales 19.38%
Interest Coverage 1.17
Cash Conversion 67.13%
Profit Quality N/A
Current Ratio 1.75
Quick Ratio 1.52
Altman-Z 0.34
F-Score5
WACC6.92%
ROIC/WACC0.68
Cap/Depr(3y)76.54%
Cap/Depr(5y)57.36%
Cap/Sales(3y)17.15%
Cap/Sales(5y)14.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-280.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-147.04%
EPS Next Y78.13%
EPS Next 2Y49.43%
EPS Next 3Y35.3%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.52%
Revenue growth 3Y13.25%
Revenue growth 5Y-0.76%
Sales Q2Q%0.11%
Revenue Next Year11.97%
Revenue Next 2Y10.11%
Revenue Next 3Y7.81%
Revenue Next 5YN/A
EBIT growth 1Y-13.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year282.71%
EBIT Next 3Y67.24%
EBIT Next 5YN/A
FCF growth 1Y-86.07%
FCF growth 3Y-58.66%
FCF growth 5Y-44.51%
OCF growth 1Y-8.85%
OCF growth 3Y10.68%
OCF growth 5Y-3.21%